Arkolith/Insider Trading/TARA/Form 4/A

Levy Richard S

DirectorProtara Therapeutics, Inc. (TARA) · full profile →Form 4/A · filed May 19, 2025
Net Buying
Open-Market Buys
$64K
Open-Market Sells
$0
Net Open-Market Flow
$64K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 14, 2025Buy(P)20K$3.19$64K51K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001213900-25-045399) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML